According to an article on 20minutos.es, a Spanish scientist named Joaquín Guzmán has created a medication that could potentially slow down several types of cancer. The medicine is called BN201, and it targets a protein called HSP90 that helps cancer cells survive and multiply. By inhibiting HSP90, BN201 could stop cancer cells from growing and potentially lead to the death of the cells.
The article reports that Guzmán and his team have tested BN201 on animals and seen promising results, with the medication appearing to be well-tolerated and effective in slowing down tumor growth. They are now working on getting approval for clinical trials in humans. The article also notes that BN201 is just one of several HSP90 inhibitors being developed worldwide, but Guzmán believes his medication has some unique properties that could make it more effective than others.
Overall, the article suggests that BN201 could be a significant breakthrough in cancer treatment and highlights the importance of continued research in this field.